Astrana Health (NASDAQ:ASTH) Reaches New 52-Week High – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH)’s share price reached a new 52-week high on Monday . The company traded as high as $44.99 and last traded at $44.5560, with a volume of 4113 shares trading hands. The stock had previously closed at $44.51.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. TD Cowen increased their price objective on Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Robert W. Baird set a $45.00 target price on shares of Astrana Health in a research report on Friday, May 8th. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Weiss Ratings upgraded shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 1st. Finally, BTIG Research reiterated a “buy” rating and issued a $50.00 price objective on shares of Astrana Health in a research note on Tuesday, June 2nd. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Astrana Health currently has a consensus rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Price Performance

The firm has a market cap of $2.48 billion, a PE ratio of 73.00 and a beta of 1.00. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The company has a 50 day moving average price of $37.46 and a 200 day moving average price of $28.79.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to the consensus estimate of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.Astrana Health’s quarterly revenue was up 55.6% on a year-over-year basis. During the same period last year, the business posted $0.42 EPS. On average, sell-side analysts expect that Astrana Health, Inc. will post 1.25 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Signaturefd LLC increased its position in shares of Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after buying an additional 388 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after buying an additional 871 shares in the last quarter. Strs Ohio acquired a new stake in Astrana Health in the 4th quarter valued at about $40,000. Tower Research Capital LLC TRC grew its stake in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after acquiring an additional 3,517 shares during the last quarter. Finally, State of Wyoming purchased a new position in Astrana Health during the 2nd quarter valued at about $132,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.